-
1
-
-
80053088189
-
Hepatocellular carcinoma
-
El-Serag, H. B. Hepatocellular carcinoma N. Engl. J. Med. 2011, 365 (12) 1118-27
-
(2011)
N. Engl. J. Med.
, vol.365
, Issue.12
, pp. 1118-1127
-
-
El-Serag, H.B.1
-
2
-
-
84891740035
-
Chemopreventive strategies in hepatocellular carcinoma
-
Singh, S.; Singh, P. P.; Roberts, L. R.; Sanchez, W. Chemopreventive strategies in hepatocellular carcinoma Nat. Rev. Gastroenterol. Hepatol. 2014, 11 (1) 45-54
-
(2014)
Nat. Rev. Gastroenterol. Hepatol.
, vol.11
, Issue.1
, pp. 45-54
-
-
Singh, S.1
Singh, P.P.2
Roberts, L.R.3
Sanchez, W.4
-
3
-
-
84859212951
-
Hepatocellular carcinoma
-
Forner, A.; Llovet, J. M.; Bruix, J. Hepatocellular carcinoma Lancet 2012, 379 (9822) 1245-55
-
(2012)
Lancet
, vol.379
, Issue.9822
, pp. 1245-1255
-
-
Forner, A.1
Llovet, J.M.2
Bruix, J.3
-
4
-
-
84857358680
-
Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?
-
Asghar, U.; Meyer, T. Are there opportunities for chemotherapy in the treatment of hepatocellular cancer? J. Hepatol. 2012, 56 (3) 686-695
-
(2012)
J. Hepatol.
, vol.56
, Issue.3
, pp. 686-695
-
-
Asghar, U.1
Meyer, T.2
-
5
-
-
47949116252
-
Sorafenib in advanced hepatocellular carcinoma
-
Llovet, J. M.; Ricci, S.; Mazzaferro, V.; Hilgard, P.; Gane, E.; Blanc, J. F.; de Oliveira, A. C.; Santoro, A.; Raoul, J. L.; Forner, A.; Schwartz, M.; Porta, C.; Zeuzem, S.; Bolondi, L.; Greten, T. F.; Galle, P. R.; Seitz, J. F.; Borbath, I.; Haussinger, D.; Giannaris, T.; Shan, M.; Moscovici, M.; Voliotis, D.; Bruix, J. Group, S. I. S. Sorafenib in advanced hepatocellular carcinoma N. Engl. J. Med. 2008, 359 (4) 378-90
-
(2008)
N. Engl. J. Med.
, vol.359
, Issue.4
, pp. 378-390
-
-
Llovet, J.M.1
Ricci, S.2
Mazzaferro, V.3
Hilgard, P.4
Gane, E.5
Blanc, J.F.6
De Oliveira, A.C.7
Santoro, A.8
Raoul, J.L.9
Forner, A.10
Schwartz, M.11
Porta, C.12
Zeuzem, S.13
Bolondi, L.14
Greten, T.F.15
Galle, P.R.16
Seitz, J.F.17
Borbath, I.18
Haussinger, D.19
Giannaris, T.20
Shan, M.21
Moscovici, M.22
Voliotis, D.23
Bruix, J.24
more..
-
6
-
-
55749088393
-
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
-
Wilhelm, S. M.; Adnane, L.; Newell, P.; Villanueva, A.; Llovet, J. M.; Lynch, M. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling Mol. Cancer Ther. 2008, 7 (10) 3129-3140
-
(2008)
Mol. Cancer Ther.
, vol.7
, Issue.10
, pp. 3129-3140
-
-
Wilhelm, S.M.1
Adnane, L.2
Newell, P.3
Villanueva, A.4
Llovet, J.M.5
Lynch, M.6
-
7
-
-
57749189578
-
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial
-
Cheng, A. L.; Kang, Y. K.; Chen, Z.; Tsao, C. J.; Qin, S.; Kim, J. S.; Luo, R.; Feng, J.; Ye, S.; Yang, T. S.; Xu, J.; Sun, Y.; Liang, H.; Liu, J.; Wang, J.; Tak, W. Y.; Pan, H.; Burock, K.; Zou, J.; Voliotis, D.; Guan, Z. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial Lancet Oncol. 2009, 10 (1) 25-34
-
(2009)
Lancet Oncol.
, vol.10
, Issue.1
, pp. 25-34
-
-
Cheng, A.L.1
Kang, Y.K.2
Chen, Z.3
Tsao, C.J.4
Qin, S.5
Kim, J.S.6
Luo, R.7
Feng, J.8
Ye, S.9
Yang, T.S.10
Xu, J.11
Sun, Y.12
Liang, H.13
Liu, J.14
Wang, J.15
Tak, W.Y.16
Pan, H.17
Burock, K.18
Zou, J.19
Voliotis, D.20
Guan, Z.21
more..
-
8
-
-
84872596428
-
Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma
-
Shen, Y. C.; Ou, D. L.; Hsu, C.; Lin, K. L.; Chang, C. Y.; Lin, C. Y.; Liu, S. H.; Cheng, A. L. Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma Br. J. Cancer 2013, 108 (1) 72-81
-
(2013)
Br. J. Cancer
, vol.108
, Issue.1
, pp. 72-81
-
-
Shen, Y.C.1
Ou, D.L.2
Hsu, C.3
Lin, K.L.4
Chang, C.Y.5
Lin, C.Y.6
Liu, S.H.7
Cheng, A.L.8
-
9
-
-
77954224898
-
Sorafenib: Where do we go from here?
-
Siegel, A. B.; Olsen, S. K.; Magun, A.; Brown, R. S. Sorafenib: Where do we go from here? Hepatology 2010, 52 (1) 360-369
-
(2010)
Hepatology
, vol.52
, Issue.1
, pp. 360-369
-
-
Siegel, A.B.1
Olsen, S.K.2
Magun, A.3
Brown, R.S.4
-
10
-
-
84904597808
-
Recent advances in curcumin nanoformulation for cancer therapy
-
Lee, W. H.; Loo, C. Y.; Young, P. M.; Traini, D.; Mason, R. S.; Rohanizadeh, R. Recent advances in curcumin nanoformulation for cancer therapy Expert Opin. Drug Delivery 2014, 11 (8) 1183-201
-
(2014)
Expert Opin. Drug Delivery
, vol.11
, Issue.8
, pp. 1183-1201
-
-
Lee, W.H.1
Loo, C.Y.2
Young, P.M.3
Traini, D.4
Mason, R.S.5
Rohanizadeh, R.6
-
11
-
-
79551639050
-
Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma
-
Wilken, R.; Veena, M. S.; Wang, M. B.; Srivatsan, E. S. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma Mol. Cancer 2011, 10, 12
-
(2011)
Mol. Cancer
, vol.10
, pp. 12
-
-
Wilken, R.1
Veena, M.S.2
Wang, M.B.3
Srivatsan, E.S.4
-
12
-
-
78649726904
-
Curcumin induced HepG2 cell apoptosis-associated mitochondrial membrane potential and intracellular free Ca(2+) concentration
-
Wang, M.; Ruan, Y.; Chen, Q.; Li, S.; Wang, Q.; Cai, J. Curcumin induced HepG2 cell apoptosis-associated mitochondrial membrane potential and intracellular free Ca(2+) concentration Eur. J. Pharmacol. 2011, 650 (1) 41-7
-
(2011)
Eur. J. Pharmacol.
, vol.650
, Issue.1
, pp. 41-47
-
-
Wang, M.1
Ruan, Y.2
Chen, Q.3
Li, S.4
Wang, Q.5
Cai, J.6
-
13
-
-
84870549754
-
Enhanced apoptotic effect of curcumin loaded solid lipid nanoparticles
-
Vandita, K.; Shashi, B.; Santosh, K. G.; Pal, K. I. Enhanced apoptotic effect of curcumin loaded solid lipid nanoparticles Mol. Pharmaceutics 2012, 9 (12) 3411-21
-
(2012)
Mol. Pharmaceutics
, vol.9
, Issue.12
, pp. 3411-3421
-
-
Vandita, K.1
Shashi, B.2
Santosh, K.G.3
Pal, K.I.4
-
14
-
-
84879297257
-
Chemopreventive and chemotherapeutic potential of curcumin in breast cancer
-
Sinha, D.; Biswas, J.; Sung, B.; Aggarwal, B. B.; Bishayee, A. Chemopreventive and chemotherapeutic potential of curcumin in breast cancer Curr. Drug Targets 2012, 13 (14) 1799-819
-
(2012)
Curr. Drug Targets
, vol.13
, Issue.14
, pp. 1799-1819
-
-
Sinha, D.1
Biswas, J.2
Sung, B.3
Aggarwal, B.B.4
Bishayee, A.5
-
15
-
-
84874114084
-
Curcumin in various cancers
-
Shehzad, A.; Lee, J.; Lee, Y. S. Curcumin in various cancers BioFactors 2013, 39 (1) 56-68
-
(2013)
BioFactors
, vol.39
, Issue.1
, pp. 56-68
-
-
Shehzad, A.1
Lee, J.2
Lee, Y.S.3
-
16
-
-
84893694889
-
Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment
-
Naksuriya, O.; Okonogi, S.; Schiffelers, R. M.; Hennink, W. E. Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment Biomaterials 2014, 35 (10) 3365-3383
-
(2014)
Biomaterials
, vol.35
, Issue.10
, pp. 3365-3383
-
-
Naksuriya, O.1
Okonogi, S.2
Schiffelers, R.M.3
Hennink, W.E.4
-
17
-
-
84893254391
-
The combined effect of encapsulating curcumin and C6 ceramide in liposomal nanoparticles against osteosarcoma
-
Dhule, S. S.; Penfornis, P.; He, J.; Harris, M. R.; Terry, T.; John, V.; Pochampally, R. The combined effect of encapsulating curcumin and C6 ceramide in liposomal nanoparticles against osteosarcoma Mol. Pharmaceutics 2014, 11 (2) 417-27
-
(2014)
Mol. Pharmaceutics
, vol.11
, Issue.2
, pp. 417-427
-
-
Dhule, S.S.1
Penfornis, P.2
He, J.3
Harris, M.R.4
Terry, T.5
John, V.6
Pochampally, R.7
-
18
-
-
84879707211
-
Synergistic interaction of paclitaxel and curcumin with cyclodextrin polymer complexation in human cancer cells
-
Boztas, A. O.; Karakuzu, O.; Galante, G.; Ugur, Z.; Kocabas, F.; Altuntas, C. Z.; Yazaydin, A. O. Synergistic interaction of paclitaxel and curcumin with cyclodextrin polymer complexation in human cancer cells Mol. Pharmaceutics 2013, 10 (7) 2676-83
-
(2013)
Mol. Pharmaceutics
, vol.10
, Issue.7
, pp. 2676-2683
-
-
Boztas, A.O.1
Karakuzu, O.2
Galante, G.3
Ugur, Z.4
Kocabas, F.5
Altuntas, C.Z.6
Yazaydin, A.O.7
-
19
-
-
67249106291
-
Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells
-
Ganta, S.; Amiji, M. Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells Mol. Pharm. 2009, 6 (3) 928-39
-
(2009)
Mol. Pharm.
, vol.6
, Issue.3
, pp. 928-939
-
-
Ganta, S.1
Amiji, M.2
-
20
-
-
84896051529
-
The use of lipid-coated nanodiamond to improve bioavailability and efficacy of sorafenib in resisting metastasis of gastric cancer
-
Zhang, Z.; Niu, B.; Chen, J.; He, X.; Bao, X.; Zhu, J.; Yu, H.; Li, Y. The use of lipid-coated nanodiamond to improve bioavailability and efficacy of sorafenib in resisting metastasis of gastric cancer Biomaterials 2014, 35 (15) 4565-4572
-
(2014)
Biomaterials
, vol.35
, Issue.15
, pp. 4565-4572
-
-
Zhang, Z.1
Niu, B.2
Chen, J.3
He, X.4
Bao, X.5
Zhu, J.6
Yu, H.7
Li, Y.8
-
21
-
-
37549051274
-
Bioavailability of curcumin: Problems and promises
-
Anand, P.; Kunnumakkara, A. B.; Newman, R. A.; Aggarwal, B. B. Bioavailability of curcumin: problems and promises Mol.Pharm. 2007, 4 (6) 807-18
-
(2007)
Mol.Pharm.
, vol.4
, Issue.6
, pp. 807-818
-
-
Anand, P.1
Kunnumakkara, A.B.2
Newman, R.A.3
Aggarwal, B.B.4
-
22
-
-
84906898076
-
Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: Synthesis, pharmacokinetics, and tumor growth inhibition
-
Wei, X.; Senanayake, T. H.; Bohling, A.; Vinogradov, S. V. Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition Mol. Pharmaceutics 2014, 11 (9) 3112-22
-
(2014)
Mol. Pharmaceutics
, vol.11
, Issue.9
, pp. 3112-3122
-
-
Wei, X.1
Senanayake, T.H.2
Bohling, A.3
Vinogradov, S.V.4
-
23
-
-
84888883621
-
Nanoparticles for combination drug therapy
-
Ma, L.; Kohli, M.; Smith, A. Nanoparticles for combination drug therapy ACS Nano 2013, 7 (11) 9518-25
-
(2013)
ACS Nano
, vol.7
, Issue.11
, pp. 9518-9525
-
-
Ma, L.1
Kohli, M.2
Smith, A.3
-
24
-
-
70450281271
-
Small-molecule-directed nanoparticle assembly towards stimuli-responsive nanocomposites
-
Zhao, Y.; Thorkelsson, K.; Mastroianni, A. J.; Schilling, T.; Luther, J. M.; Rancatore, B. J.; Matsunaga, K.; Jinnai, H.; Wu, Y.; Poulsen, D.; Frechet, J. M. J.; Alivisatos, A. P.; Xu, T. Small-molecule-directed nanoparticle assembly towards stimuli-responsive nanocomposites Nat. Mater. 2009, 8 (12) 979-985
-
(2009)
Nat. Mater.
, vol.8
, Issue.12
, pp. 979-985
-
-
Zhao, Y.1
Thorkelsson, K.2
Mastroianni, A.J.3
Schilling, T.4
Luther, J.M.5
Rancatore, B.J.6
Matsunaga, K.7
Jinnai, H.8
Wu, Y.9
Poulsen, D.10
Frechet, J.M.J.11
Alivisatos, A.P.12
Xu, T.13
-
25
-
-
84915785213
-
Nanoassembly of probucol enables novel therapeutic efficacy in the suppression of lung metastasis of breast cancer
-
Zhang, Z.; Cao, H.; Jiang, S.; Liu, Z.; He, X.; Yu, H.; Li, Y. Nanoassembly of probucol enables novel therapeutic efficacy in the suppression of lung metastasis of breast cancer Small 2014, 10 (22) 4735-45
-
(2014)
Small
, vol.10
, Issue.22
, pp. 4735-4745
-
-
Zhang, Z.1
Cao, H.2
Jiang, S.3
Liu, Z.4
He, X.5
Yu, H.6
Li, Y.7
-
26
-
-
77955524173
-
Directed self-assembly of nanoparticles
-
Grzelczak, M.; Vermant, J.; Furst, E. M.; Liz-Marzan, L. M. Directed self-assembly of nanoparticles ACS Nano 2010, 4 (7) 3591-605
-
(2010)
ACS Nano
, vol.4
, Issue.7
, pp. 3591-3605
-
-
Grzelczak, M.1
Vermant, J.2
Furst, E.M.3
Liz-Marzan, L.M.4
-
27
-
-
84871603300
-
Hydrophobic interactions modulate self-assembly of nanoparticles
-
Sanchez-Iglesias, A.; Grzelczak, M.; Altantzis, T.; Goris, B.; Perez-Juste, J.; Bals, S.; Van Tendeloo, G.; Donaldson, S. H.; Chmelka, B. F.; Israelachvili, J. N.; Liz-Marzan, L. M. Hydrophobic interactions modulate self-assembly of nanoparticles ACS Nano 2012, 6 (12) 11059-11065
-
(2012)
ACS Nano
, vol.6
, Issue.12
, pp. 11059-11065
-
-
Sanchez-Iglesias, A.1
Grzelczak, M.2
Altantzis, T.3
Goris, B.4
Perez-Juste, J.5
Bals, S.6
Van Tendeloo, G.7
Donaldson, S.H.8
Chmelka, B.F.9
Israelachvili, J.N.10
Liz-Marzan, L.M.11
-
28
-
-
80052550748
-
Efficient and facile formation of two-component nanoparticles via aromatic moiety directed self-assembly
-
Wang, W.; Chau, Y. Efficient and facile formation of two-component nanoparticles via aromatic moiety directed self-assembly Chem. Commun. 2011, 47 (37) 10224-6
-
(2011)
Chem. Commun.
, vol.47
, Issue.37
, pp. 10224-10226
-
-
Wang, W.1
Chau, Y.2
-
29
-
-
84894596307
-
Directed self-assembled nanoparticles of probucol improve oral delivery: Fabrication, performance and correlation
-
Zhang, Z.; Jiang, S.; Liu, Z.; Niu, B.; Gu, W.; Li, Y.; Cui, J. Directed self-assembled nanoparticles of probucol improve oral delivery: fabrication, performance and correlation Pharm. Res. 2014, 31 (9) 2266-75
-
(2014)
Pharm. Res.
, vol.31
, Issue.9
, pp. 2266-2275
-
-
Zhang, Z.1
Jiang, S.2
Liu, Z.3
Niu, B.4
Gu, W.5
Li, Y.6
Cui, J.7
-
30
-
-
84877083541
-
The inhibition of metastasis and growth of breast cancer by blocking the NF-κB signaling pathway using bioreducible PEI-based/p65 shRNA complex nanoparticles
-
Xiao, J.; Duan, X.; Yin, Q.; Miao, Z.; Yu, H.; Chen, C.; Zhang, Z.; Wang, J.; Li, Y. The inhibition of metastasis and growth of breast cancer by blocking the NF-κB signaling pathway using bioreducible PEI-based/p65 shRNA complex nanoparticles Biomaterials 2013, 34 (21) 5381-5390
-
(2013)
Biomaterials
, vol.34
, Issue.21
, pp. 5381-5390
-
-
Xiao, J.1
Duan, X.2
Yin, Q.3
Miao, Z.4
Yu, H.5
Chen, C.6
Zhang, Z.7
Wang, J.8
Li, Y.9
-
31
-
-
84861151846
-
Use of the mouse aortic ring assay to study angiogenesis
-
Baker, M.; Robinson, S. D.; Lechertier, T.; Barber, P. R.; Tavora, B.; D'Amico, G.; Jones, D. T.; Vojnovic, B.; Hodivala-Dilke, K. Use of the mouse aortic ring assay to study angiogenesis Nat. Protoc. 2012, 7 (1) 89-104
-
(2012)
Nat. Protoc.
, vol.7
, Issue.1
, pp. 89-104
-
-
Baker, M.1
Robinson, S.D.2
Lechertier, T.3
Barber, P.R.4
Tavora, B.5
D'Amico, G.6
Jones, D.T.7
Vojnovic, B.8
Hodivala-Dilke, K.9
-
32
-
-
84907976699
-
Simultaneous inhibition of tumor growth and angiogenesis for resistant hepatocellular carcinoma by co-delivery of sorafenib and survivin small hairpin RNA
-
Shen, J.; Sun, H.; Meng, Q.; Yin, Q.; Zhang, Z.; Yu, H.; Li, Y. Simultaneous inhibition of tumor growth and angiogenesis for resistant hepatocellular carcinoma by co-delivery of sorafenib and survivin small hairpin RNA Mol. Pharmaceutics 2014, 11 (10) 3342-51
-
(2014)
Mol. Pharmaceutics
, vol.11
, Issue.10
, pp. 3342-3351
-
-
Shen, J.1
Sun, H.2
Meng, Q.3
Yin, Q.4
Zhang, Z.5
Yu, H.6
Li, Y.7
-
33
-
-
84878652021
-
Reversal of multidrug resistance by mitochondrial targeted self-assembled nanocarrier based on stearylamine
-
Zhang, Z.; Liu, Z.; Ma, L.; Jiang, S.; Wang, Y.; Yu, H.; Yin, Q.; Cui, J.; Li, Y. Reversal of multidrug resistance by mitochondrial targeted self-assembled nanocarrier based on stearylamine Mol. Pharmaceutics 2013, 10 (6) 2426-34
-
(2013)
Mol. Pharmaceutics
, vol.10
, Issue.6
, pp. 2426-2434
-
-
Zhang, Z.1
Liu, Z.2
Ma, L.3
Jiang, S.4
Wang, Y.5
Yu, H.6
Yin, Q.7
Cui, J.8
Li, Y.9
-
34
-
-
84902215667
-
Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs
-
Markovsky, E.; Baabur-Cohen, H.; Satchi-Fainaro, R. Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs J. Controlled Release 2014, 187 (0) 145-157
-
(2014)
J. Controlled Release
, vol.187
, Issue.0
, pp. 145-157
-
-
Markovsky, E.1
Baabur-Cohen, H.2
Satchi-Fainaro, R.3
-
35
-
-
84905283740
-
Enhanced antitumor efficacy and counterfeited cardiotoxicity of combinatorial oral therapy using Doxorubicin- and Coenzyme Q10-liquid crystalline nanoparticles in comparison with intravenous Adriamycin
-
Swarnakar, N. K.; Thanki, K.; Jain, S. Enhanced antitumor efficacy and counterfeited cardiotoxicity of combinatorial oral therapy using Doxorubicin- and Coenzyme Q10-liquid crystalline nanoparticles in comparison with intravenous Adriamycin Nanomed. NBM 2014, 10 (6) 1231-1241
-
(2014)
Nanomed. NBM
, vol.10
, Issue.6
, pp. 1231-1241
-
-
Swarnakar, N.K.1
Thanki, K.2
Jain, S.3
-
36
-
-
84885172782
-
Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin e TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer
-
Mi, Y.; Zhao, J.; Feng, S. S. Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer J. Controlled Release 2013, 169 (3) 185-92
-
(2013)
J. Controlled Release
, vol.169
, Issue.3
, pp. 185-192
-
-
Mi, Y.1
Zhao, J.2
Feng, S.S.3
-
37
-
-
84877245753
-
Inhibitory effect of paclitaxel and rapamycin individual and dual drug-loaded polymeric micelles in the angiogenic cascade
-
Mishra, G. P.; Nguyen, D.; Alani, A. W. Inhibitory effect of paclitaxel and rapamycin individual and dual drug-loaded polymeric micelles in the angiogenic cascade Mol.Pharm. 2013, 10 (5) 2071-8
-
(2013)
Mol.Pharm.
, vol.10
, Issue.5
, pp. 2071-2078
-
-
Mishra, G.P.1
Nguyen, D.2
Alani, A.W.3
-
38
-
-
84872099658
-
A self-assembled nanocarrier loading teniposide improves the oral delivery and drug concentration in tumor
-
Zhang, Z.; Ma, L.; Jiang, S.; Liu, Z.; Huang, J.; Chen, L.; Yu, H.; Li, Y. A self-assembled nanocarrier loading teniposide improves the oral delivery and drug concentration in tumor J. Controlled Release 2013, 166 (1) 30-7
-
(2013)
J. Controlled Release
, vol.166
, Issue.1
, pp. 30-37
-
-
Zhang, Z.1
Ma, L.2
Jiang, S.3
Liu, Z.4
Huang, J.5
Chen, L.6
Yu, H.7
Li, Y.8
-
39
-
-
78651379634
-
Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism
-
Gao, F.; Zhang, Z. W.; Bu, H. H.; Huang, Y.; Gao, Z. W.; Shen, J. N.; Zhao, C. J.; Li, Y. P. Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism J. Controlled Release 2011, 149 (2) 168-174
-
(2011)
J. Controlled Release
, vol.149
, Issue.2
, pp. 168-174
-
-
Gao, F.1
Zhang, Z.W.2
Bu, H.H.3
Huang, Y.4
Gao, Z.W.5
Shen, J.N.6
Zhao, C.J.7
Li, Y.P.8
-
40
-
-
60449093312
-
Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: Results from a phase i extension trial
-
Richly, H.; Schultheis, B.; Adamietz, I. A.; Kupsch, P.; Grubert, M.; Hilger, R. A.; Ludwig, M.; Brendel, E.; Christensen, O.; Strumberg, D. Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: results from a phase I extension trial Eur. J. Cancer 2009, 45 (4) 579-87
-
(2009)
Eur. J. Cancer
, vol.45
, Issue.4
, pp. 579-587
-
-
Richly, H.1
Schultheis, B.2
Adamietz, I.A.3
Kupsch, P.4
Grubert, M.5
Hilger, R.A.6
Ludwig, M.7
Brendel, E.8
Christensen, O.9
Strumberg, D.10
-
41
-
-
78349298645
-
Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: A randomized trial
-
Abou-Alfa, G. K.; Johnson, P.; Knox, J. J.; Capanu, M.; Davidenko, I.; Lacava, J.; Leung, T.; Gansukh, B.; Saltz, L. B. Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial JAMA 2010, 304 (19) 2154-60
-
(2010)
JAMA
, vol.304
, Issue.19
, pp. 2154-2160
-
-
Abou-Alfa, G.K.1
Johnson, P.2
Knox, J.J.3
Capanu, M.4
Davidenko, I.5
Lacava, J.6
Leung, T.7
Gansukh, B.8
Saltz, L.B.9
|